General MedicationsINJECTIONGeneric
CEPHALOTHIN SODIUM
CEPHALOTHIN SODIUM
Standard Dose
EQ 2GM BASE/VIAL
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary
Approval overview CEPHALOTHIN SODIUM is listed in Drugs@FDA under application 062666 (ANDA).
Marketing status: Discontinued Active ingredient CEPHALOTHIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Sponsor ABRAXIS PHARM Submission history See approval history documents.
Structured Monograph
Clinical summary
Approval overview CEPHALOTHIN SODIUM is listed in Drugs@FDA under application 062666 (ANDA). Marketing status: Discontinued Active ingredient CEPHALOTHIN SODIUM Form and strength INJECTABLE;INJECTION - EQ 2GM BASE/VIAL Sponsor ABRAXIS PHARM Submission history See approval history documents.
Monitoring
- • Review priority: STANDARD
- • Marketing status: Discontinued
Interaction Notes
- No interaction notes stored yet.